Imatinib

Sold as Vativio, Gleevec, Imavec, Sunmatin, Vativio fc, Nazzec, Imatinib accord, Mivesta, Imatinib adco, Imturas

C₂₉H₃₁N₇O493.60 g/mol

4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide

Drag to rotate. Structure from PubChem CID 5291.

Loading Wikipedia summary

Registration

Applicants: 8
Registrations: 18
Schedule source: Consolidated Schedules 06 July 2026

Applicants and registrations

Applicant	Brands	Dosages	Registrations	Schedule	Leaflets
Novartis South Africa (Pty) Ltd1 of 5 cancelled	Vativio, Gleevec, Vativio fc	10 mg/400 mg, 100 mg/400mg, 400	360139, 380143, 380144, 460367, 460368	S4	PI PIL
Cipla Medpro (Pty) Ltd	Imavec	Not stated	420496	S4	None
Ranbaxy Pharmaceutical (Pty) Ltd	Sunmatin	100, 400	440886, 440887	S4	None
Sandoz South Africa (Pty) LtdCancelled	Nazzec	100, 400	460369, 460370	S4	None
Accord Healthcare (Pty) Ltd	Imatinib accord	100mg, 400mg	490740, 490741	S4	None
Eurolab (Pty) Ltd	Mivesta	100mg, 400mg	490742, 490743	S4	None
Adcock Ingram Critical Care (Pty) Ltd	Imatinib adco	100 mg, 400 mg	530187, 530188	S4	None
Pharma-q Holdings (Pty) Ltd	Imturas	100 mg, 400 mg	570023, 570024	S4	None

Variants

Product	Strength and form	Registration	Status	Schedule	Leaflets
Vativio 100 EACH CAPSULE CONTAINS IMATINIB 100,0 mg	10 mg/400 mgFilm-coated tablets	36013936/34/0139Approved 3 February 2026	Cancelled	S4	PI PIL
Gleevec EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100 mg/400mgFilm-coated tablets	38014338/34/0143Approved 3 February 2026	Registered	S4	PI PIL
Gleevec 400 EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400	38014438/34/0144	Registered	S4	None
Imavec EACH CAPSULE CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	Not listed	42049642/34/0496	Registered	S4	None
Sunmatin 100 EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100	44088644/26/0886	Registered	S4	None
Sunmatin 400 EACH TABLET CONTAINS: IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400	44088744/26/0887	Registered	S4	None
Vativio fc EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	Not listed	46036746/26/0367	Registered	S4	None
Vativio 400 EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	10 mg/400 mgFilm-coated tablets	46036846/26/0368Approved 3 February 2026	Registered	S4	PI PIL
Nazzec 100 EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100	46036946/26/0369	Cancelled	S4	None
Nazzec 400 EACH TABLET CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400	46037046/26/0370	Cancelled	S4	None
Imatinib accord 100mg EACH TABLET CONTAINS :IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100mg	49074049/26/0740	Registered	S4	None
Imatinib accord 400mg EACH TABLET CONTAINS :IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400mg	49074149/26/0741	Registered	S4	None
Mivesta 100mg EACH TABLET CONTAINS : IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100mg	49074249/26/0742	Registered	S4	None
Mivesta 400mg EACH TABLET CONTAINS : IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400mg	49074349/26/0743	Registered	S4	None
Imatinib 100 MG adco EACH TABLETS CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 100,0 mg	100 mg	53018753/34/0187	Registered	S4	None
Imatinib 400 MG adco EACH TABLETS CONTAINS IMATINIB MESILATE EQUIVALENT TO IMATINIB 400,0 mg	400 mg	53018853/34/0188	Registered	S4	None
Imturas 100 MG EACH TABLET CONTAINS :IMATINIB MESILATE 100,0 mg	100 mg	57002357/26/0023	Registered	S4	None
Imturas 400 MG EACH TABLET CONTAINS IMATINIB MESILATE 400,0 mg	400 mg	57002457/26/0024	Registered	S4	None

Regulatory status

Where S4 sits on the scale

S0S1S2S3S4S5S6S7S8

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence high.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Imatinib

S4: Imatinib
Consolidated Schedules 06 July 2026, line 6726

Pharmacological class: Complementary Medicines: Health Supplements (class 34)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Professional information (PI)For healthcare professionalsVativio 100, Novartis South Africa (Pty) Ltd Patient information leaflet (PIL)For patients and carersVativio 100, Novartis South Africa (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading PubMed articles

Background